Integration and task shifting for TB/HIV care and treatment in highly resource-scarce settings: One size may not fit all

Journal of Acquired Immune Deficiency Syndromes

Volumn 65, Issue 3, 2014, Pages

  Van Rie, Annelies ^a   Patel, Monita R ^a   Nana, Mbonze ^b   Vanden Driessche, Koen ^a   Tabala, Martine ^b   Yotebieng, Marcel ^a,b   Behets, Frieda ^a  

^a IL   (United States)

^b UNIVERSITY OF KINSHASA   (Congo)

Author keywords

antiretroviral therapy; delay; integration; nurses; timing; tuberculosis

Indexed keywords

ADULT; ANTI-RETROVIRAL AGENTS; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DEMOCRATIC REPUBLIC OF THE CONGO; DRUG UTILIZATION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TUBERCULOSIS;

EID: 84894461966     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/01.qai.0000434954.65620.f3     Document Type: Article

References (34)

1. World Health Organization. Global Tuberculosis Report 2013. Geneva, Switzerland: World Health Organization; 2013. WHO/HTM/TB/2013.11
2. Lawn SD, Campbell L, Kaplan R, et al. Delays in starting antiretroviral therapy in patients with HIV-Associated tuberculosis accessing nonintegrated clinical services in a South African township. BMC Infect Dis. 2011;11:258
3. Lawn SD, Harries AD, Williams BG, et al. Antiretroviral therapy and the control of HIV-Associated tuberculosis. Will ART do it?. Int J Tuberc Lung Dis. 2011;15:571-581
4. Naidoo K, Baxter C, Karim SSA. When to start antiretroviral therapy during tuberculosis treatment?. Curr Opin Infect Dis. 2013;26:35-42
5. Abdool Karim SS, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011;365: 1492-1501
6. Blanc FX, Sok T, Laureillard D, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011;365:1471-1481
7. Havlir DV, Kendall MA, Ive P, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011;365:1482-1491
8. Legido-Quigley H, Montgomery CM, Khan P, et al. Integrating tuberculosis and HIV services in low-And middle-income countries: A systematic review. Trop Med Int Health. 2013;18:199-211
9. Friedland G, Harries A, Coetzee D. Implementation issues in tuberculosis/ HIV program collaboration and integration: 3 case studies. J Infect Dis. 2007;196:S114-S123
10. Sanne I, Orrell C, Fox MP, et al. Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): A randomised non-inferiority trial. Lancet. 2010;376:33-40
11. Fairall L, Bachmann MO, Lombard C, et al. Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): A pragmatic, parallel, cluster-randomised trial. Lancet. 2012;380:889-898
12. Martinot A, Van Rie A, Mulangu S, et al. Baseline assessment of collaborative tuberculosis/HIV activities in Kinshasa, the Democratic Republic of Congo. Trop Doct. 2008;38:137-141
13. National Institute of Allergy and Infectious Diseases, Division of AIDS. Table for Grading the Severity of Adult and Pediatric Adverse Events. Bethesda, Maryland: National Institute of Allergy and Infectious Diseases; 2004
14. Henegar C, Behets F, Vanden Driessche K, et al. Mortality among tuberculosis patients in the Democratic Republic of Congo. Int J Tuberc Lung Dis. 2012;16:1199-1204
15. World Health Organization. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Geneva, Switzerland: World Health Organization; 2011. WHO/NMH/NHD/ MNM/11.1
16. Kerschberger B, Hilderbrand K, Boulle AM, et al. The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: A before-After study. PLoS One. 2012;7:e46988
17. Huerga H, Spillane H, Guerrero W, et al. Impact of introducing human immunodeficiency virus testing, treatment and care in a tuberculosis clinic in rural Kenya. Int J Tuberc Lung Dis. 2010;14:611-615
18. Vasan A, Kenya-Mugisha N, Seung KJ, et al. Agreement between physicians and non-physician clinicians in starting antiretroviral therapy in rural Uganda. Hum Resour Health. 2009;7:75
19. Bedelu M, Ford N, Hilderbrand K, et al. Implementing antiretroviral therapy in rural communities: The Lusikisiki model of decentralized HIV/AIDS care. J Infect Dis. 2007;196(suppl 3):S464-S468
20. Bemelmans M, Van Den Akker T, Ford N, et al. Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care. Trop Med Int Health. 2010;15: 1413-1420
21. Callaghan M, Ford N, Schneider H. A systematic review of task-shifting for HIV treatment and care in Africa. Hum Resour Health. 2010;8:8
22. Cohen R, Lynch S, Bygrave H, et al. Antiretroviral treatment outcomes from a nurse-driven, community-supported HIV/AIDS treatment programme in rural Lesotho: Observational cohort assessment at two years. J Int AIDS Soc. 2009;12:23
23. Colvin CJ, Fairall L, Lewin S, et al. Expanding access to ART in South Africa: The role of nurse-initiated treatment. S Afr Med J. 2010; 100:210-212
24. Ivers LC, Jerome JG, Cullen KA, et al. Task-shifting in HIV care: A case study of nurse-centered community-based care in Rural Haiti. PLoS One. 2011;6:e19276
25. Shumbusho F, van Griensven J, Lowrance D, et al. Task shifting for scale-up of HIV care: Evaluation of nurse-centered antiretroviral treatment at rural health centers in Rwanda. PLoS Med. 2009;6:e1000163
26. Zachariah R, Ford N, Philips M, et al. Task shifting in HIV/AIDS: Opportunities, challenges and proposed actions for sub-Saharan Africa. Trans R Soc Trop Med Hyg. 2009;103:549-558
27. Gandhi NR, Moll AP, Lalloo U, et al. Successful integration of tuberculosis and HIV treatment in rural South Africa: The Sizonqoba study. J Acquir Immune Defic Syndr. 2009;50:37-43
28. World Health Organization. WHO Policy on Collaborative TB/HIV Activities: Guidelines for National Programmes and Other Stakeholders. Geneva, Switzerland: World Health Organization; 2012. WHO/HTM/TB/2012.6
29. Wong EB, Omar T, Setlhako GJ, et al. Causes of death on antiretroviral therapy: A post-mortem study from South Africa. PloS One. 2012;7:e47542
30. Cain KP, Anekthananon T, Burapat C, et al. Causes of death in HIVinfected persons who have tuberculosis, Thailand. Emerg Infect Dis. 2009;15:258
31. Kantipong P, Murakami K, Moolphate S, et al. Causes of mortality among tuberculosis and HIV co-infected patients in Chiang Rai, Northern Thailand. HIV AIDS (Auckl). 2012;4:159
32. Lawn SD, Myer L, Bekker LG, et al. Tuberculosis-Associated immune reconstitution disease: Incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS. 2007;21:335-341
33. McIlleron H, Meintjes G, Burman WJ, et al. Complications of antiretroviral therapy in patients with tuberculosis: Drug interactions, toxicity, and immune reconstitution inflammatory syndrome. J Infect Dis. 2007;196: S63-S75
34. Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010;362: 697-706